0000899243-18-031133.txt : 20181214
0000899243-18-031133.hdr.sgml : 20181214
20181214201247
ACCESSION NUMBER: 0000899243-18-031133
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181212
FILED AS OF DATE: 20181214
DATE AS OF CHANGE: 20181214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Maduck Sean
CENTRAL INDEX KEY: 0001698310
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50679
FILM NUMBER: 181236820
MAIL ADDRESS:
STREET 1: C/O CORCEPT THERAPEUTICS INCORPORATED
STREET 2: 149 COMMONWEALTH DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CORCEPT THERAPEUTICS INC
CENTRAL INDEX KEY: 0001088856
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770487658
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 149 COMMONWEALTH DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650.688.8803
MAIL ADDRESS:
STREET 1: 149 COMMONWEALTH DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-12-12
0
0001088856
CORCEPT THERAPEUTICS INC
CORT
0001698310
Maduck Sean
C/O CORCEPT THERAPEUTICS INCORPORATED
149 COMMONWEALTH DRIVE
MENLO PARK
CA
94025
0
1
0
0
See Remarks
Common Stock
2018-12-12
4
M
0
44991
2.61
A
65015
D
Common Stock
2018-12-12
4
M
0
15009
3.29
A
80024
D
Common Stock
2018-12-12
4
S
0
60000
19.0061
D
20024
D
Common Stock
2018-12-13
4
M
0
10000
2.24
A
30024
D
Common Stock
10000
I
See Footnote
Common Stock
10000
I
See Footnote
Stock Option (Right to Buy)
2.61
2018-12-12
4
M
0
44991
0.00
D
2024-08-07
Common Stock
44991
55009
D
Stock Option (Right to Buy)
3.29
2018-12-12
4
M
0
15009
0.00
D
2025-02-18
Common Stock
15009
234991
D
Stock Option (Right to Buy)
2.24
2018-12-13
4
M
0
10000
0.00
D
2022-11-01
Common Stock
10000
25000
D
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $18.75 to $19.48 per share. Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.
Represents the shares held by Duckhill Capital, LLC of which the reporting person is President and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.
Represents the shares held by Sean and Molly Maduck Living Trust of which the reporting person is a co-trustee.
Fully exercisable.
Shares subject to this stock option vest and become exercisable at the rate of 1/48th of the total number of shares on each monthly anniversary of February 18, 2015, so that the total number of shares subject to this option becomes fully vested and exercisable on February 18, 2019.
Senior Vice President, Commercial
/s/ Sean Nicholas Maduck
2018-12-14